The latest closing stock price for Enlivex Therapeutics as of September 18, 2024 is 1.55.
An investor who bought $1,000 worth of Enlivex Therapeutics stock at the IPO in 2014 would have $-995 today, roughly -1 times their original investment - a -41.60% compound annual growth rate over 10 years.
The all-time high Enlivex Therapeutics stock closing price was 391.60 on August 27, 2014.
The Enlivex Therapeutics 52-week high stock price is 4.59, which is 196.1% above the current share price.
The Enlivex Therapeutics 52-week low stock price is 1.15, which is 25.8% below the current share price.
The average Enlivex Therapeutics stock price for the last 52 weeks is 2.01.
An investor who bought $1,000 worth of Enlivex Therapeutics stock at the IPO in 2014 would have $-995 today, roughly -1 times their original investment - a -41.60% compound annual growth rate over 10 years.
The all-time high Enlivex Therapeutics stock closing price was 391.60 on August 27, 2014.
The Enlivex Therapeutics 52-week high stock price is 4.59, which is 196.1% above the current share price.
The Enlivex Therapeutics 52-week low stock price is 1.15, which is 25.8% below the current share price.
The average Enlivex Therapeutics stock price for the last 52 weeks is 2.01.